Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fritsch

Showing results (381-390 of 400) with videos related to

Pageof 40
Sort By:
Health Physics|September 15, 2010
Structure of a single model to describe plutonium and americium decorporation by DTPA treatmentsP Fritsch, A L Sérandour, O Grémy, et al.
Deutsche Medizinische Wochenschrift (1946)|April 15, 1983
[Preoperative diagnosis of intra-abdominal diseases. Reliability of sonography and computer tomography]J Erckenbrecht, W Naus, P Peter, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Report on consensus meeting of the EORTC Melanoma Group on educational needs for primary and secondary prevention of melanoma in Europe. Results of a workshop held under the auspices of the EEC Europe against cancer programme in Innsbruck, April 1991R M MacKie, A Osterlind, D Ruiter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma. Austrian Malignant Melanoma Cooperative GroupH Pehamberger, H P Soyer, A Steiner, et al.
Radiation Protection Dosimetry|June 15, 2007
Decorporation of plutonium by pulmonary administration of Ca-DTPA dry powder: a study in rat after lung contamination with different plutonium formsA L Sérandour, N Tsapis, C Gervelas, et al.
Canadian Journal of Physiology and Pharmacology|August 20, 2002
[Specific parameters for the calculation of dose after aerosol inhalation of transuranium elements]B Ramounet-Le Gall, P Fritsch, M C Abram, et al.
Gynakologische Rundschau|January 1, 1991
[Intracutaneous test for detection of cellular immune reactions to HPV-16 proteins in patients with CIN]K Heim, R Höpfl, M Sandbichler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2000
Production of IL-12 by human monocyte-derived dendritic cells is optimal when the stimulus is given at the onset of maturation, and is further enhanced by IL-4S Ebner, G Ratzinger, B Krösbacher, et al.
Radiation Protection Dosimetry|April 9, 2009
Biokinetic modelling of DTPA decorporation therapy: the CONRAD approachB Breustedt, E Blanchardon, P Berard, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 24, 2007
Direct lung delivery of a dry powder formulation of DTPA with improved aerosolization properties: effect on lung and systemic decorporation of plutoniumC Gervelas, A-L Serandour, S Geiger, et al.
Pageof 40

Showing results (381-390 of 400) with videos related to

Sort By:
Pageof 40
Health Physics|September 15, 2010
Structure of a single model to describe plutonium and americium decorporation by DTPA treatmentsP Fritsch, A L Sérandour, O Grémy, et al.
Deutsche Medizinische Wochenschrift (1946)|April 15, 1983
[Preoperative diagnosis of intra-abdominal diseases. Reliability of sonography and computer tomography]J Erckenbrecht, W Naus, P Peter, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Report on consensus meeting of the EORTC Melanoma Group on educational needs for primary and secondary prevention of melanoma in Europe. Results of a workshop held under the auspices of the EEC Europe against cancer programme in Innsbruck, April 1991R M MacKie, A Osterlind, D Ruiter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma. Austrian Malignant Melanoma Cooperative GroupH Pehamberger, H P Soyer, A Steiner, et al.
Radiation Protection Dosimetry|June 15, 2007
Decorporation of plutonium by pulmonary administration of Ca-DTPA dry powder: a study in rat after lung contamination with different plutonium formsA L Sérandour, N Tsapis, C Gervelas, et al.
Canadian Journal of Physiology and Pharmacology|August 20, 2002
[Specific parameters for the calculation of dose after aerosol inhalation of transuranium elements]B Ramounet-Le Gall, P Fritsch, M C Abram, et al.
Gynakologische Rundschau|January 1, 1991
[Intracutaneous test for detection of cellular immune reactions to HPV-16 proteins in patients with CIN]K Heim, R Höpfl, M Sandbichler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2000
Production of IL-12 by human monocyte-derived dendritic cells is optimal when the stimulus is given at the onset of maturation, and is further enhanced by IL-4S Ebner, G Ratzinger, B Krösbacher, et al.
Radiation Protection Dosimetry|April 9, 2009
Biokinetic modelling of DTPA decorporation therapy: the CONRAD approachB Breustedt, E Blanchardon, P Berard, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 24, 2007
Direct lung delivery of a dry powder formulation of DTPA with improved aerosolization properties: effect on lung and systemic decorporation of plutoniumC Gervelas, A-L Serandour, S Geiger, et al.
Pageof 40